LYRM4 and non-small cell lung carcinoma: Overexpression of LYRM4[T] partly alleviated these erastin‐induced morphological changes in NSCLC cells, compared with control and LYRM4[G] overexpression group (Figure 6J; and Figure S13G, Supporting Information).